The government is currently fine-tuning the detailed draft of Pharmaceutical Reevaluation Standard and Method.

Although the initial drafting schedule disclosed at last year’s meeting with pharmaceutical industry and public hearing has been delayed, the government’s commitment on the task is still strong regardless of the urgent issues like the infectious disease outbreak.

Ministry of Health and Welfare (MOHW) and Health Insurance Review and Assessment Service (HIRA) have briefed the draft of reevaluation guideline at the Drug Reimbursement Evacuation Committee’s (DREC) February meeting and mentioned of some changes and selecting subjects for pilot program.

Apparent